The Aussies control AMDL Diagnostics. They have transferred the Trademarks out of Radient Pharmaceuticals into AMDL Diagnostics.
Did RXPC Shareholders approve the Trademark Transfer? Did RXPC Shareholders control these transactions? Do RXPC Shareholders have any say about what the Aussies do with Radient or its assets? Do RXPC shareholders benefit in aqny way from the transfer of Trademarks out of Radient Pharmaceuticals into any of the AMDL entities?
Answers: No, No, No, and No.
Regarding the statement "when Mac was CEO of Radient he could start a corporation and take all of RAdienta nd AMDL Diagnostics assets and stock and transfer it to his EWELLNESS corporation.." You are correct, as CEO he could do all that. if RXPC shareholders and/or lenders wanted retribution they would have to sue him and the company for "breaches of fiduciary duties of care, loyalty, good faith and disclosure, self dealing and waste and spoliation of corporate assets."
Sound familiar?
And nobody is saying the Aussies own RXPC stock or AMDL Diagnostics stock. RXPC stock is worthless so who cares who owns that... and the legal owner of AMDL Diagnostics stock is still Radient Pharmaceuticals as far as we know. Radient is an insolvent voided corporation that cannot conduct business and cannot legally object to whatever AMDL Diagnostics does.
The important thing to take away from the Trademark Transactions is: if anyone wants to pay licensing fees for the Trademark names, they pay those to AMDL, not Radient, preventing Radient's creditors and/or shareholders from sueing to retrieve the money. It's just business.
